Hua Yu

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type <i>KRAS</i> Exon 2 Metastatic Colorectal Cancer

Lee S. Schwartzberg, Fernando Rivera, Meinolf Karthaus et al. · Journal of Clinical Oncology · 2014 · 632 citations

Medicine, Oncology, Pharmacology +12

Analysis of <i>KRAS</i> / <i>NRAS</i> Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Marc Peeters, Kelly S. Oliner, Timothy Price et al. · Clinical Cancer Research · 2015 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Rice Triosephosphate Isomerase Gene 5[prime] Sequence Directs [beta]-Glucuronidase Activity in Transgenic Tobacco but Requires an Intron for Expression in Rice

Yanfang Xu, Hua Yu, Timothy C. Hall · PLANT PHYSIOLOGY · 1994 · 41 citations · Full text

Life Sciences, Biotechnology, Plant Sciences +8

Updated analysis of <i>KRAS/NRAS </i>and<i> BRAF </i>mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).

Marc Peeters, Kelly S. Oliner, Timothy Price et al. · Journal of Clinical Oncology · 2014 · 37 citations

Medicine, Molecular Medicine, Oncology +17

[Drinking water types, microcystins and colorectal cancer].

Lili Zhou, Dandan Yu, Hua Yu et al. · PubMed · 2000 · 28 citations

Medicine, Oncology, Toxicology +17